Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks

Metabolic Brain Disease

Volumn 28, Issue 4, 2013, Pages 629-638

  Ljubisavljevic, Srdjan ^a,b   Stojanovic, Ivana ^b   Vojinovic, Slobodan ^a   Milojkovic, Maja ^b   Dunjic, Olivera ^b   Stojanov, Dragan ^a   Pavlovic, Dusica ^b  

^a Clinical Centre Nis   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

Bilirubin; Clinically isolated syndrome; Relapsing remitting multiple sclerosis; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INTERFERON; URIC ACID;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DEMYELINATING DISEASE; DISEASE DURATION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; BILIRUBIN; BRAIN; DEMYELINATING DISEASES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; URIC ACID;

EID: 84887235065     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-013-9409-z     Document Type: Article

References (44)

1. Acar AA, Cevik MU, Evliyaoglu O, Uzar E, Tamam Y, ArIkanoglu A, Yucel Y, Varol S, Onder H, Taşdemir N (2012) Evaluation of serum oxidant/antioxidant balance in multiple sclerosis. Acta Neurol Belg 112(3):275-280
2. Amorini AM, Petzold A, Tavazzi B, Eikelenboom J, Keir G, Belli A, Giovannoni G, Di Pietro V, Polman C, D'Urso S, Vagnozzi R, Uitdehaag B, Lazzarino G (2009) Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients. Clin Biochem 42:1001-1006
3. Bermel RA, Inglese M (2013) Neurodegeneration and inflammation in MS. The eye teaches us about the storm. Neurology 80(1):19-20
4. Chen J, Tu Y, Connolly EC, Ronnett GV (2005) Heme oxygenase-2 protects against glutathione depletion-induced neuronal apoptosis mediated by bilirubin and cyclic GMP. Curr Neurovasc Res 2:121-131
5. Constantinescu CS, Freitag P, Kappos L (2000) Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis. Mult Scler 6(6):378-381
6. Drulovic J, Dujmovic I, Stojsavljevic N, Mesaros S, Andjelkovic S, Miljkovic D, Peric V, Dragutinovic G, Marinkovic J, Levic Z, Mostarica Stojkovic M (2001) Uric acid levels in sera from patients with multiple sclerosis. J Neurol 248(2):121-126
7. Emerson MR, LeVine SM (2000) Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: an expanded view of the stress response. J Neurochem 75:2555-2562
8. Genc S, Genc K, Kumral A, Baskin H, Ozkan H (2003) Bilirubin is cytotoxic to rat oligodendrocytes in vitro. Brain Res 985:135-141
9. Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251(3):261-268
10. Gonsette RE (2008) Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Mult Scler 14:22-34
11. Gonsette RE, Sindic C, Dhooghe MB, De Deyn PP, Medaer R, Michotte A, Seeldrayers P, Guillaume D, ASIIMS Study Group (2010) Boosting endogenous neuroprotection in multiple sclerosis: the association of inosine and interferon beta in relapsing-remitting multiple sclerosis (ASIIMS) trial. Mult Scler 16:455-462
12. Guerrero AL, MartIn-Polo J, Laherran E, Gutierrez F, Iglesias F, Tejero MA, Rodríguez-Gallego M, Alcázar C (2008) Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment. Eur J Neurol 15:394-397
13. Guerrero L, Gutierrez F, Iglesias F, MartIn-Polo J, Merino S, MartIn-Serradilla JI, Laherran E, Tejero MA (2011) Serum uric acid levels in multiple sclerosis patients inversely correlate with disability. Neurol Sci 32:347-350
14. Hediger MA (2002) Gateway to a long life? Nature 417:393-395
15. Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV (2000) Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 14(5):691-698
16. Kanabrocki EL, Ryan MD, Hermida RC, Ayala DE, McCormick JB, Dawson S, Lojo L, Hoffman HS, Siegel G, Friedman N, Eladasori B, Parachuri R, Nemchausky BA (2008) Uric acid and renal function in multiple sclerosis. Clin Ter 159:35-40
17. Kapitulnik J (2004) Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 66:773-779
18. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2009) Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 61:885-888
19. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
20. Liu Y, Zhu B, Luo L, Li P, Paty DW, Cynader MS (2001) Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. NeuroReport 12:1841-1845
21. Liu Y, Zhu B, Wang X, Luo L, Li P, Paty DW, Cynader MS (2003) Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. J Neuroimmunol 139:27-35
22. Ljubisavljevic S, Stojanovic I, Pavlovic R, Stojnev S, Stevanovic I, Sokolovic D, Pavlovic D (2012) The reduced glutathione and S nitrosothiols levels in acute phase of experimental demyelination - pathophysiological approach and possible clinical relevancy. Neuroscience 219:175-182
23. Ljubisavljevic S, Stojanovic I, Vojinovic S, Stojanov D, Stojanovic S, Cvetkovic T, Savic D, Pavlovic D (2013) The patients with clinically isolated syndrome and relapsing remitting multiples sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF. Neurochem Int 62(7):988-997
24. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey - National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
25. Lundvig DMS, Immenschuh S, Wagener FA (2012) Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? Front Pharmacol 3:81
26. Maher P, Schubert D (2000) Signaling by reactive oxygen species in the nervous system. Cell Mol Life Sci 57:1287-1305
27. Mehindate K, Sahlas DJ, Frankel D, Mawal Y, Liberman A, Corcos J, Dion S, Schipper HM (2001) Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J Neurochem 77:1386-1395
28. Oliveira SR, Kallaur AP, Simao ANC, Morimoto HK, Lopes J, Panis C, Petenucci DL, Silva E, Cecchini R, Kaimen-Maciel DR, Reiche EMV (2012) Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale. J Neurol Sci 321(1-2):49-53
29. Peng F, Zhong X, Deng X, Qiu W, Wu A, Long Y, Hu X, Li Q, Jiang Y, Dai Y (2010) Serum uric acid levels and neuromyelitis optica. J Neurol 257:1021-1026
30. Peng F, Deng X, Yu Y, Chen X, Shen L, Zhong X, Qiu W, Jiang Y, Zhang J, Hu X (2011) Serum bilirubin concentrations and multiple sclerosis. J Clin Neurosci 18:1355-1359
31. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292-302
32. Ramsaransing GSM, Heersema DJ, De Keyser J (2005) Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs progressive multiple sclerosis. Eur J Neurol 12:514-518
33. Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RHC, Barkhof F, Polman CH, Uitdehaag BMJ, Giovannoni G (2004) CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 63:1439-1445
34. Rentzos M, Nikolaou C, Anagnostouli M, Rombos A, Tsakanikas K, Economou M, Dimitrakopoulos A, Karouli M, Vassilopoulos D (2006) Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg 108(6):527-531
35. Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583-650
36. Salemi G, Gueli MC, Vitale F, Battaglieri F, Guglielmini E, Ragonese P, Trentacosti A, Massenti MF, Savettieri G, Bono A (2010) Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. Lipids Health Dis 9:19-21
37. Salvatore Orefice N, Ferraro O, Barbato F, Carotenuto A, Lanzillo R, Brescia Morra V, Coppola G, Orefice G (2012) Biochemical parameters alterations in multiple sclerosis: a longitudinal study and review of the literature. Pharmacol Pharm 3:248-253
38. Sautin YY, Johnson RJ (2008) Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 27:608-619
39. Scott GS, Hooper DC (2001) The role of uric acid in protection against peroxynitrite-mediated pathology. Med Hypotheses 56(1):95-100
40. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH (2009) Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. PNAS 106(13):5171-5176
41. Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Fois ML, Arru G, Rosati G (2002) Serum uric acid and multiple sclerosis. Neurol Sci 23(4):183-188
42. Toncev G, Milicic B, Toncev S, Samardzic G (2002a) High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels. Clin Chem Lab Med 40(5):505-508
43. Toncev G, Milicic B, Toncev S, Samardzic G (2002b) Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol 9(3):221-226
44. Usha SA, Vickneshwaran V, Sanat KS, Thiagaragan G (2011) Bilirubin and uric acid in traumatic brain injury. J Global Pharma Technol 3(11):20-24